Reply [6]

Indian Pediatrics

Volumn 44, Issue 9, 2007, Pages 711-712

  Singhal, Tanu ^a   Amdekar, Y K ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INJECTABLE POLIO VACCINE; MATERNAL ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY TITER; DRUG EFFICACY; HUMAN; IMMUNIZATION; INDIA; LETTER; POLIOMYELITIS; PREVALENCE; RISK BENEFIT ANALYSIS; VACCINATION;

EID: 34948909640     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Poliomyelitis Prevention in the United States. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR May 19, 2000; 49: 1-22.
2. Kohler KA, Banerjee K, Gary Hlady W, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull World Health Organ 2002; 80: 210-216.
3. Onorato I, Modlin J, McBean AM, Thoms ML, Losonsky GA, Bernier RH, et al. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163: 1-6.